The invention relates to novel aminopyridine derivatives of formula (I) wherein R1 is methyl an R4 and amino group —NR6R7 and R5 forms an arylalkynyl- or heteroarylalkynyl-group. The compounds are useful in the prevention or treatment of central nervous system disorders as well as other disorders modulated by mGluR5 receptors
该发明涉及公式(I)的新型
氨基
吡啶衍生物,其中R1为甲基,R4和
氨基基团- NR6R7,R5形成芳基炔基或杂环芳基炔基基团。这些化合物在预防或治疗中枢神经系统疾病以及其他受mGluR5受体调节的疾病方面很有用。